Jane Street’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$305K Sell
103,427
-481
-0.5% -$801 ﹤0.01% 9180
2026
Q1
$104K Sell
103,908
-1,021
-1% -$982 ﹤0.01% 10636
2025
Q4
$35.7K Sell
104,929
-199
-0.2% -$67 ﹤0.01% 10598
2025
Q3
$36.3K Sell
105,128
-437
-0.4% -$124 ﹤0.01% 10424
2025
Q2
$24.8K Sell
105,565
-319
-0.3% -$71 ﹤0.01% 9330
2025
Q1
$25.2K Sell
105,884
-771
-0.7% -$230 ﹤0.01% 9116
2024
Q4
$22.4K Buy
106,655
+611
+0.6% +$125 ﹤0.01% 9116
2024
Q3
$20.7K Buy
106,044
+358
+0.3% +$74 ﹤0.01% 9292
2024
Q2
$25K Buy
105,686
+561
+0.5% +$133 ﹤0.01% 9022
2024
Q1
$26.3K Buy
+105,125
New +$27.8K ﹤0.01% 8864
2022
Q2
Sell
-105,548
Closed -$64K 9864
2022
Q1
$64K Buy
+105,548
New +$57.6K ﹤0.01% 9615

Other funds holding DRTSW

Jane Street's DRTSW Position: Q2 2026 in Review

Jane Street reduced its Alpha Tau Medical Warrant (DRTSW) stake by 0.46% in Q2 2026, selling an estimated $801 and leaving 103,427 shares worth $305K. The position accounts for ﹤0.01% of the portfolio, ranked #9180.

Jane Street first reported a position in DRTSW in Q1 2022 and has held it in 11 quarters since. 21 funds tracked by Wall St. Rank hold DRTSW as of Q2 2026.

  • Jane Street held 103,427 shares of Alpha Tau Medical Warrant worth $305K as of Q2 2026.
  • Jane Street sold 481 Alpha Tau Medical Warrant shares in Q2 2026, an estimated $801.
  • Alpha Tau Medical Warrant made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #9180 holding.
  • Jane Street first reported a position in Alpha Tau Medical Warrant in Q1 2022 and has held it in 11 quarters since.
  • 21 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.